ÂÜÀòÂÒÂ×

Imago BioSciences

0 followers

‌

Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor

Employees

51-200

Links

Org chart

Hugh Y. Rienhoff, Jr.

Collapse
Michael Arenberg
Chief Operating & Business Officer
Wan-Jen Hong
Chief Medical Officer
Amy E. Tapper
SVP, Non-Clinical & CMC
Allison Anderson, MAS
Head of People & Talent
Amy Tapper
Chief Technology Officer
Cassandra Celatka
Exec. Director, Drug Discovery and Development
Ian Houts
Senior Director Supply Chain
Maria Kleppe
Senior Director, Scientific Discovery
Stephanie Roland
Vice President Regulatory Affairs